These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 17407514

  • 1. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens.
    Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T.
    BJU Int; 2007 Mar; 99(3):554-8. PubMed ID: 17407514
    [Abstract] [Full Text] [Related]

  • 2. Incidental prostate cancer in radical cystoprostatectomy specimens.
    Jin XD, Chen ZD, Wang B, Cai SL, Yao XL, Jin BY.
    Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G, Barbatis C, Plastiras D, Mertziotis N, Katsifotis C, Presvelos V, Theodorou C.
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
    Damiano R, Di Lorenzo G, Cantiello F, De Sio M, Perdonà S, D'Armiento M, Autorino R.
    Eur Urol; 2007 Sep; 52(3):648-57. PubMed ID: 17600614
    [Abstract] [Full Text] [Related]

  • 15. Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?
    Sanli O, Acar O, Celtik M, Oktar T, Kilicaraslan I, Ozcan F, Tunc M, Esen T.
    Urol Int; 2006 Sep; 77(4):307-10. PubMed ID: 17135779
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
    Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML.
    BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.